Notice2023-08564
National Institute on Drug Abuse; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 24, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 78 (Monday, April 24, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 78 (Monday, April 24, 2023)]
[Notices]
[Pages 24823-24824]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-08564]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; HEAL Initiative: Therapeutics Development for Opioid
Use Disorder in Patients with Co-occurring Mental Disorders (UG3/
UH3).
Date: May 23, 2023.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Division of Extramural Research, Scientific Review
Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5702,
<a href="/cdn-cgi/l/email-protection#fb8892959f938ed5909281939a90909e969a9f9a8f939297bb959293d59c948d"><span class="__cf_email__" data-cfemail="9ceff5f2f8f4e9b2f7f5e6f4fdf7f7f9f1fdf8fde8f4f5f0dcf2f5f4b2fbf3ea">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Developed Regulated Therapeutic and Diagnostic
Solutions for Patients Affected by Opioid and/or Stimulants Use
Disorders.
Date: June 1, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Shareen Amina Iqbal, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 443-4577, <a href="/cdn-cgi/l/email-protection#a6d5cec7d4c3c3c888cfd7c4c7cae6c8cfce88c1c9d0"><span class="__cf_email__" data-cfemail="4a39222b382f2f2464233b282b260a242322642d253c">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; BRAIN Initiative: Brain-Behavior Quantification and
Synchronization--Transformative and Integrative Models of Behavior
at the Organismal Level.
Date: June 5, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 594-9460, <a href="/cdn-cgi/l/email-protection#7d2e1204120813531e15123d131415531a120b"><span class="__cf_email__" data-cfemail="1a497563756f74347972755a747372347d756c">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; BRAIN Initiative: Brain-Behavior Quantification and
Synchronization--Transformative and Integrative Models of Behavior
at the Organismal Level.
Date: June 7, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 594-9460, <a href="/cdn-cgi/l/email-protection#297a4650465c47074a414669474041074e465f"><span class="__cf_email__" data-cfemail="b0e3dfc9dfc5de9ed3d8dff0ded9d89ed7dfc6">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Functional Validation and/or Characterization of
Genes or Variants Implicated in SUD.
Date: June 5, 2023.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ipolia R. Ramadan, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, Bethesda, MD 20892, (301)
827-4471, <a href="/cdn-cgi/l/email-protection#7d0f1c101c191c13140f3d101c141153131415531a120b"><span class="__cf_email__" data-cfemail="6a180b070b0e0b0403182a070b030644040302440d051c">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; HEAL Initiative: Preventing Opioid Misuse and Co-
Occurring Conditions by Intervening on Social Determinants (R01).
Date: June 8, 2023.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Marisa Srivareerat, Ph.D., Scientific Review
Officer, Scientific Review Branch, Office of Extramural Policy,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 435-1258,
<a href="/cdn-cgi/l/email-protection#d2bfb3a0bba1b3fca1a0bba4b3a0b7b7a0b3a692bcbbbafcb5bda4"><span class="__cf_email__" data-cfemail="c9a4a8bba0baa8e7babba0bfa8bbacacbba8bd89a7a0a1e7aea6bf">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist
[[Page 24824]]
Development Award for Clinicians, Scientist Development Awards, and
Research Scientist Awards; 93.278, Drug Abuse National Research
Service Awards for Research Training; 93.279, Drug Abuse and
Addiction Research Programs, National Institutes of Health, HHS)
Dated: April 18, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-08564 Filed 4-21-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 24, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.